Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention: Primary Results of the STRIVE Trial

被引：0
|
作者：
Goadsby, P. J. [1 ]
Reuter, U. [2 ]
Bonner, J. [3 ]
Broessner, G. [4 ]
Hallstrom, Y. [5 ]
Zhang, F. [6 ]
Sapra, S. [6 ]
Picard, H. [6 ]
Mikol, D. D. [6 ]
Lenz, R. A. [6 ]
机构：
[1] Kings Coll Hosp London, London, England
[2] Charite, Berlin, Brandenburg, Germany
[3] Mercy Res, St Louis, MO USA
[4] Med Univ Innsbruck, Innsbruck, Austria
[5] Stockholm Neuro Ctr, Stockholms Lan, Sweden
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
HEADACHE | 2017年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IOR04
引用
收藏
页码：128 / 129
页数：2
相关论文
共 50 条
  • [31] Efficacy of erenumab (AMG 334) in chronic migraine patients with prior prophylactic treatment failure: Subgroup analysis of the phase 2, randomised, double-blind, placebo-controlled study
    Ashina, Messoud
    Tepper, Stewart J.
    Brandes, Jan Lewis
    Reuter, Uwe
    Boudreau, Guy P.
    Dolezil, David
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert A.
    Klatt, Jan
    Mikol, Daniel D.
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [32] Phase 1, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Erenumab (AMG 334) and Concomitant Sumatriptan on Blood Pressure in Healthy Subjects
    de Noon, Jan
    Van Hecken, Anne
    Vandermeulen, Corinne
    Herbots, Marissa
    Kubo, Yumi
    Lee, Ed
    Eisele, Osa
    Vargas, Gabriel
    Gabriel, Kristin
    NEUROLOGY, 2017, 88
  • [33] Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers
    de Hoon, Jan
    van Hecken, Anne
    Vandermeulen, Corinne
    Herbots, Marissa
    Kubo, Yumi
    Lee, Ed
    Eisele, Osa
    Vargas, Gabriel
    Gabriel, Kristin
    CEPHALALGIA, 2019, 39 (01) : 100 - 110
  • [34] Reducing Impaired Days: Results from the STRIVE Trial, A Phase 3, Randomized, Double-Blind Study of Erenumab for Episodic Migraine
    Hareendran, Asha
    Buse, Dawn C.
    Lipton, Richard B.
    Bayliss, Martha S.
    Mikol, Daniel D.
    Revicki, Dennis A.
    Zhang, Feng
    Desai, Pooja
    Picard, Hernan
    Kawata, Ariane K.
    CEPHALALGIA, 2017, 37 : 275 - 276
  • [35] Reducing the Impact of Migraine on Functioning: Results from the STRIVE Trial: A Phase 3, Randomized, Double-Blind Study of Erenumab in Subjects with Episodic Migraine
    Buse, Dawn C.
    Lipton, Richard B.
    Mikol, Daniel D.
    Thach, Andrew V.
    Desai, Pooja
    Picard, Hernan
    Kubo, Yumi
    Hareendran, Asha
    Kawata, Ariane K.
    CEPHALALGIA, 2017, 37 : 195 - 196
  • [36] Efficacy and Safety of Cinnarizine in the Prophylaxis of Migraine in Children: A Double-Blind Placebo-Controlled Randomized Trial
    Ashrafi, Mahmoud Reza
    Salehi, Soodeh
    Malamiri, Reza Azizi
    Heidari, Morteza
    Hosseini, Seyed Ahmad
    Samiei, Mahboubeh
    Tavasoli, Ali Reza
    Togha, Mansoureh
    PEDIATRIC NEUROLOGY, 2014, 51 (04) : 503 - 508
  • [37] Response to topiramate in the prevention of chronic migraine: results of a double-blind, randomized, placebo-controlled trial
    Grazzi, L.
    Diener, H-C
    Van Oene, J. C.
    Lahaye, M.
    Schwalen, S.
    Goadsby, P. J.
    CEPHALALGIA, 2006, 26 (11) : 1368 - 1368
  • [38] Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
    Silberstein, Stephen D.
    Lipton, Richard B.
    Dodick, David W.
    Freitag, Frederick G.
    Ramadan, Nabih
    Mathew, Ninan
    Brandes, Jan L.
    Bigal, Marcelo
    Saper, Joel
    Ascher, Steven
    Jordan, Donna M.
    Greenberg, Steven J.
    Hulihan, Joseph
    HEADACHE, 2007, 47 (02): : 170 - 180
  • [39] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
  • [40] Patient-Reported Outcomes in Patients with Chronic Migraine Receiving Placebo or Erenumab (AMG 334) in a Phase 2, Randomized, Double-Blind Study
    Tepper, Stewart
    Lipton, Richard
    Reuter, Uwe
    Silberstein, Stephen
    Stewart, Walter
    Leonardi, Dean
    Desai, Pooja
    Cheng, Sunfa
    Mikol, Dan
    Lenz, Robert
    NEUROLOGY, 2017, 88
12345